NCT01945216View on ClinicalTrials.gov

"Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

CompletedOBSERVATIONAL
Enrollment

3,317

Participants

Timeline

Start Date

July 8, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
Interventions
DRUG

Alogliptin

Alogliptin tablets

Trial Locations (1)

Unknown

Osaka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01945216 - "Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI" | Biotech Hunter | Biotech Hunter